For the third consecutive year, Louisiana lawmakers have rejected a bill that would have allowed abortion access to minors who become pregnant as a result of rape. The proposed legislation, authored by Democratic Representative Delisha Boyd, sought to expand the state’s near-total abortion ban by permitting exceptions for girls under the age of 17 who are victims of sexual assault.

In an emotionally charged legislative committee meeting on Tuesday, several lawmakers cited their religious beliefs as the reason for voting against the measure. Despite impassioned pleas from supporters of the bill, it failed in a 3-9 vote, with two Democrats joining Republicans in opposition.

Also Read: Aamir Khan Opens Up About His Son Junaid's Struggle With Dyslexia

Abortion Law in Louisiana: A Deeply Personal and Painful Debate

Both Boyd and fellow Democratic Representative Patricia Moore have personal ties to the issue—they were born after their mothers were raped as teenagers. Boyd, born in 1969, just four years before Roe v. Wade legalized abortion nationwide, emphasized that her mother did not have a choice. “I know the Bible. But I also know God gives people the ability to do right and wrong,” she said during the hearing.

Moore, who represents a deeply religious constituency, expressed her inner turmoil over the bill. “I’m struggling because life and death, according to our Heavenly Father, it’s in His hands,” she said. Moore shared the tragic example of a pregnant nine-year-old girl in her district, adding to the gravity of the debate. Yet, she concluded that she could not support the bill, citing her faith and belief in divine purpose: “God would take a bad situation and turn it into good.”

Also Read: Try These 6 Low-Impact Cross-Training Moves That Actually Work

Abortion Laws in Louisiana: A National Outlier

Louisiana has one of the strictest abortion bans in the United States. The law, triggered in 2022 after the Supreme Court overturned Roe v. Wade, prohibits abortion at all stages of pregnancy. The only exceptions are when the mother’s life is at substantial risk or in cases of “medically futile” pregnancies—where the fetus has no chance of survival outside the womb.

Also Read: Exercise Proven ‘Better Than Drugs’ To Prevent Colon Cancer Recurrence, Study Trial Shows

The proposed rape exception would have added a critical layer of compassion for minors suffering extreme trauma. Advocates argue that forcing young rape survivors to carry pregnancies to term not only inflicts further psychological harm but also endangers their physical health. Louisiana, notably, has one of the highest maternal mortality rates in the country, making forced pregnancies even more dangerous for young girls.

Why It Matters: The Health and Rights of Survivors

The rejection of the bill in Louisiana is part of a broader trend seen in several Republican-led states that have enacted strict abortion bans with few or no exceptions. According to a study published in the Journal of the American Medical Association, between July 2022 and January 2024, more than 64,000 pregnancies resulted from rape in states where abortion is mostly or completely banned.

Of the 12 U.S. states enforcing total abortion bans, only four currently allow exceptions in cases of rape. Louisiana is not among them. This places an immense burden on victims, especially minors, who must either carry an unwanted pregnancy to term or travel across state lines to access care—an option not available to all due to financial, logistical, or legal barriers.

A 2019 Study titled They Are Girls, Not Mothers: The Violence of Forcing Motherhood on Young Girls in Latin America, published in Health and Human Rights Journal while looks specifically at the Latin America population, it does note for the risk it presents for the young pregnant girl, physically and mentally. The study also cites the Stolen Lives report, published by Planned Parenthood Global, it notes of the severe impact that forced motherhood and pregnancies have on women. The report also speaks to the experience of 2 million girls under 15 worldwide, who are compelled to give birth every year as a result of sexual violence.

"There are severe physical, mental, and social health impacts of forced pregnancies and motherhood," notes the study.

Physical Consequences

Research has consistently shown that forced pregnancy carries severe health risks for young girls. Among the most serious physical complications are preeclampsia and preterm labor. The danger is especially high for adolescent girls—studies show that the risk of dying during childbirth is four times greater for girls than for adult women. In fact, pregnancy and childbirth are the leading causes of death for girls aged 15 to 19 worldwide.

There are also less-documented harms. Survivors of sexual violence, particularly young girls, often face obstetric violence and mistreatment in medical settings. Healthcare providers may deny them the specialized reproductive care they need or treat them with insensitivity, ignoring the trauma and vulnerability of their situation.

In countries like Guatemala and Nicaragua, Caesarean sections have become common for adolescent pregnancies—not due to medical necessity, but because of a lack of training among medical professionals to support the specific needs of young survivors of sexual violence. These early surgeries can have long-term consequences, including surgical complications and the risk of adhesions later in life.

Psychological and Emotional Toll

The mental health impact of forced motherhood is equally severe. Feelings of anxiety, depression, fear, and hopelessness are common. Investigations by Planned Parenthood Global have linked such pregnancies to suicidal ideation and attempts, especially in places where reproductive choices are heavily restricted.

A 2019 report titled Silenced Lives found that in Alta Verapaz, Guatemala, 50% of the teenage girls who died by suicide in 2017 were pregnant. One such girl, Juana, became severely depressed after her pregnancy. In her own words: “I want to die; my heart is not happy like before.”

Social Impact

Forced motherhood drastically reshapes the social trajectory of young girls. According to the Stolen Lives report, teenage pregnancy often leads to girls dropping out of school, missing employment opportunities, and falling into cycles of poverty and dependence. Many never return to education and become stuck in low-wage jobs, prolonged unemployment, or abusive relationships.

• Teen mothers are statistically more likely to:
• Not complete high school
• Work in low-income or unstable jobs
• Depend on welfare
• Become single parents
• Live in poverty long-term

In the study spanning four countries, 33% of the girls had only attended primary school. Without education or income, these girls lose not only their future prospects but also their sense of belonging. They are often removed from school and peer groups, isolated from community life, and pushed into adult roles they are unprepared for.

Pregnancy at such a young age reinforces harmful cultural stereotypes about gender, sexuality, and power. Girls like Juana, who wished to finish school, often end up in government shelters until they reach legal adulthood, stripped of autonomy and burdened with responsibilities well before their time.

The Path Forward: Choice, Compassion, and Health

Supporters of the bill argue that being pro-life should also mean valuing the lives and mental well-being of children who are victims of sexual assault. As Boyd said, “We should also be fighting for the life of those children who are raped and molested.”

While the measure failed again this year, the growing body of evidence and rising national awareness about the consequences of such bans suggest that the debate is far from over. For now, young rape survivors in Louisiana will continue to face some of the harshest abortion restrictions in the nation—caught at the intersection of trauma, law, and faith.

Recent legal developments have highlighted the importance of advance planning for end-of-life care.

A Living Will is something every adult should consider discussing and creating at some point.

Conversations within families about individual preferences in the event of a terminal illness are an important first step, and these discussions should take place while everyone is still in good health.

Individuals may have very different views about how they wish to be treated if they develop a terminal illness or certain severe, irreversible conditions. For instance, some may not want ventilator support, while others may choose to avoid ICU care.

Some might accept ICU care but prefer not to undergo CPR. Others may prefer not to receive artificial feeding through tubes. Yet others may wish for every possible treatment to be attempted. A few may prefer to spend their final days at home.

Creating A Living Will

It should be noted that a Living Will does not impose any limitation on treatment for common medical conditions such as infections, surgery for curable illnesses, or routine hospital care.

These preferences apply only to situations such as terminal illness—for example, advanced cancer—or irreversible conditions such as a persistent vegetative state.

Creating a Living Will is now relatively straightforward. It must be signed in the presence of two witnesses and attested by a notary or a gazetted officer.

The earlier requirement of countersignature by a Judicial Magistrate has been removed to make the process easier. Templates are also available online that individuals can use as a basis for drafting their own. Before preparing one, it is helpful to discuss the pros and cons of their choices with the family doctor.

It is important to again emphasize that a Living Will is NOT about refusing all treatment, hospitalization, or ICU admission for routine medical care. Rather, it addresses only specific situations.

When such preferences are clearly documented in advance, important decisions about withholding or withdrawing treatment in select circumstances become less contentious.

Doctors and hospitals will no longer be hesitant to withhold unnecessary treatment measures in such situations, as it will already be documented in the patient’s own Living Will. Relatives also will not face the difficult decision of withholding or withdrawing futile medical treatment on behalf of their loved one.

Essentially, the Living Will protects the patient’s wishes when they are no longer able to speak for themselves.

What Happens Without A Living Will

In a terminally ill patient who is unable to communicate, the absence of a Living Will often leads to differences of opinion among family members about what the patient might have wanted.

This uncertainty frequently results in a collective decision to “do everything possible,” just to be on the safe side.

Doctors are reluctant to override the wishes of relatives, even when they believe that further treatment measures are unlikely to be beneficial.

As a result, the patient may receive prolonged medical interventions that neither improve the underlying condition nor enhance quality of life. Once started, these treatments may continue indefinitely until the patient dies naturally.

This may take months, years, or even decades, and also incur huge costs. In the absence of a Living Will, complex legal procedures are required to withdraw these treatments — even if all the relatives are convinced that they should be withdrawn.

Bolivia has reported an outbreak of mosquito-borne Chikungunya virus disease, with cases rising to more than 5,000 nationwide.

Chikungunya is transmitted by the Aedes aegypti and Aedes albopictus mosquitoes -- the same species that spread dengue fever and Zika virus disease. As a result, the disease becomes challenging to diagnose.

The South American country's Ministry of Health, in a statement, shared that "5,371 cases of chikungunya have been registered nationwide".

The worst areas in Bolivia include

• Santa Cruz (4,500 cases)
• Cochabamba (303 cases)
• Tarija (332 cases)
• Chuquisaca (81 cases)
• La Paz (68 cases)

The Ministry informed, "joint efforts to control and manage the vector".

It further noted that an investigation is being conducted to share the results and cause of death, as well as ongoing epidemiological surveillance for all vector-borne disease.

To curb the cases, the Health Ministry noted that "it is supporting the provision of biolarvicide and insecticide for departmental and municipal actions to prevent an increase in cases".

This includes the distribution of about 1,300 liters of insecticide and biological larvicides applied with backpack sprayers, Outbreak News Today reported.

The government also urged the general public to clean weeds from yards and gardens to eliminate the vector’s resting places

Global Cases

In January, the surveillance data from the European Centre for Disease Prevention and Control (ECDC) reported 2,881 cases of Chikungunya virus disease and no associated deaths from 11 countries in European Union this year.

The ECDC noted that the Americas have reported 2,879 cases and one associated death, with Brazil reporting the highest number of cases in 2026.

In addition to Bolivia, other countries in South America reporting chikungunya include Costa Rica, El Salvador, Honduras, and Mexico.

French health authorities also reported a significant rise in chikungunya disease in Mayotte, an overseas department in the Indian Ocean. Since the beginning of 2026, more than 270 confirmed cases have been recorded, Vax-Before-Travel reported.

ECDC data shows that the weekly average of cases in the last two weeks of February 2026 was around 65.

Symptoms And Prevention

There is currently no antiviral drug treatment for chikungunya. While two vaccines against chikungunya have received regulatory approval, it still lacks widespread rollout.

Common symptoms of chikungunya include:

• abrupt onset of fever
• joint and muscle pain
• headache
• nausea
• fatigue
• rash

While serious complications are rare, the elderly and children under one year old may be at risk of long-term symptoms and even death.

The ECDC advised people "to take enhanced measures to prevent mosquito bites".

India's drug regulator, the Central Drugs Standard Control Organization (CDSCO), has threatened pharmaceutical firms with action for promoting GLP-1 weight-loss drugs among the general public.

Glucagon-Like Peptide-1 (GLP-1) receptor agonists are a class of medicines that help lower blood sugar, support weight loss, reduce the risk of heart and kidney complications, and can even lower the risk of early death in people with type 2 diabetes.

In an official circular, the CDSCO warned drug makers from indulging in "direct or indirect advertising" for obesity and metabolic disorders.

The regulatory body also cautioned pharma companies against campaigns using influencers, noting that any violation "could attract regulatory action".

Advertisements, which "function as a surrogate advertisement for prescription-only drugs, shall be viewed seriously and may be treated as irrational or misleading marketing practice", read the letter signed by the Drug Controller General of India (DCGI) Rajeev Raghuvanshi.

The order comes as the CDSCO noted that drugmakers have been engaging in surrogate promotional activities, under the garb of disease awareness campaigns, and digital media outreach.

What The CDSCO Mandated

• Weight-loss drugs, specifically GLP-1 medications, must only be sold with a prescription from a registered medical practitioner.

• There should be no ads, whether direct or indirect, in print, electronic, digital, social media, or any other public platform intended, directly or indirectly, to promote the product to the general public.

• No GLP-1 drugs must exaggerate for therapeutic efficacy; suggest for assured or guaranteed weight loss outcome; and induce demand for pharmacological therapy

• awareness campaigns
• influencer engagement
• corporate campaigns

Rush For Generic Weight Loss Drugs

The government's advisory comes patent for semaglutide -- an active ingredient in diabetes and anti-obesity drugs, specifically Wegovy and Ozempic -- expires on March 20.

This will allow Indian pharma companies to launch cheaper generic versions, significantly increasing affordability and access for millions battling Type 2 diabetes and obesity.

Major Indian drugmakers gearing up to launch their generic semglutide injection in the country in March include Sun Pharmaceutical Industries, Zydus Lifesciences, Alkem Laboratories, Dr. Reddy’s Laboratories, Torrent Pharmaceuticals, and MSN Laboratories.

Obesity A Chronic Metabolic Condition

The CDSCO stressed the importance of "lifestyle modification measures (diet, exercise, behavioural interventions)" in treating obesity.

"Obesity is a chronic metabolic condition requiring comprehensive management, including lifestyle interventions," the regulator said.

"Pharmaceutical therapy, where indicated, must not be projected in a manner that undermines public health initiatives promoting diet control, physical activity, and preventive healthcare," it added.

WHO Guidelines On GLP-1 drugs

Amid increasing prevalence of GLP-1 drugs, the World Health Organisation (WHO), late last year, acknowledged its role in treating obesity.

However, it warned that medications like GLP-1 alone will not solve the problem affecting more than one billion people worldwide.

The global health body also issued conditional recommendations for using these therapies as part of a comprehensive approach that includes healthy diets, regular physical activity, and support from health professionals.